Open an account

AquaBounty Technologies

AQB · NASDAQ

$1.15+$0.11 (+10.58%)TodayMarket closed ·
Prev close $1.04

AQB analyst rating

This isn't available right now. Refresh to try again.

The case for and against

Updated Nov 14, 2024

Bull case

AquaBounty Technologies Inc. has demonstrated solid growth in production, achieving a 14.4% increase in harvested AquAdvantage Salmon (AAS) to 492MT for fiscal year 2023, highlighting the company's operational effectiveness. The ongoing global demand for land-based aquaculture solutions, coupled with AquaBounty's established market position and genetic intellectual property, enhances its appeal as a strategic partner in the industry. Additionally, the firm's initiatives to optimize operations, particularly with expanded egg incubation capacity at the PEI farm and a significant order from a major salmon producer, position it favorably for long-term revenue growth.

Bear case

AquaBounty Technologies Inc. reported stagnant sales of $733,100 for the September quarter, attributed to weak wholesale salmon pricing and the role of the Indiana fish farm primarily as a test bed rather than a significant production facility, leading to lower expectations for production expansion. The company anticipates a drastic reduction in FY24 revenue estimates, forecasting $747,000, down from $2.5 million, indicating a concerning decline in sales performance and operational efficiency. Furthermore, liquidity issues have prompted the company to secure a $10 million bridge loan, with total assets decreasing to $176.2 million, which raises concerns about its financial stability and future growth prospects.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.